HOME >> BIOLOGY >> NEWS
UK working with 20/20 GeneSystems

LEXINGTON, Ky. (Dec. 15, 2005) − The University of Kentucky has granted exclusive rights to 20/20 GeneSystems Inc. (20/20) for a new blood test that has shown exceptional accuracy for the early detection and screening of non-small cell lung cancer (NSCLC). Working with the UK team, the company 20/20 intends to develop a diagnostic that would help identify lung cancer in smokers, former smokers and other at-risk individuals at its earliest, most effectively treatable stages.

Edward Hirschowitz, M.D., and Li Zhong, Ph.D., of the Division of Pulmonary and Critical Care Medicine, UK Chandler Medical Center, along with several associates, have identified multiple antibodies that the body's immune system produces in response to lung cancer development. The presence and amounts of these antibodies in the blood predict NSCLC with better than 90 percent accuracy, including at very early stages of the disease. NSCLC comprises approximately 80 percent of all lung cancers.

Part of this research was reported in the November 2005 issue of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society. While the published work primarily involved samples from patients with advanced disease, subsequent tests on blood from persons with early-stage lung cancer detected cancerous nodules several years before they were identified using advanced CT scans. This new data directed to early detection and screening is expected to be presented in early 2006 to the National Cancer Institute (NCI) Early Detection Research Network.

According to the NCI, 160,000 people die each year from lung cancer, making it the number one cause of cancer death in America. Smoking is the primary cause of the disease. Only 25 percent of new cases of lung cancer are diagnosed at an early stage, when curative surgery is possible.

With the biomarkers identified by the UK team, 20/20 plans to create a screening test for the early de
'"/>

Contact: Louise DuPont
mldupo00@email.uky.edu
859-323-6363
University of Kentucky
16-Dec-2005


Page: 1 2

Related biology news :

1. UK scientists working to help cut ID theft
2. Neuronal activity gives clues to working memory
3. New impetus through networking
4. New imaging method shows whether treatment for advanced prostate cancer is working
5. Networking around the clock
6. Neuroscientists explain inner workings of critical pain pathway
7. FSU researchers determine a critical factor in workings of proteins
8. Walking tall: UH student working on space suit redesign for NASA
9. Researchers publish first working model that explains how biological clocks work
10. Pet owners are sick more often and exercise less than other working-aged people
11. The CReSA is working on a new strategy to combat spongiforms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2020)... ... May 22, 2020 , ... Oxford Nanopore Technologies is in advanced development of ... that causes COVID-19. , The LamPORE assay is designed to be rapid, ... very large numbers of samples. Hardware and reagents sit outside current, squeezed supply ...
(Date:5/21/2020)... ... 2020 , ... Catalent, the leading global provider of advanced ... and consumer health products, today announced that Jean-François Chaubard, Senior Director, Open Innovation ... Paris Virtual conference, which takes place on 28 – 29 May, 2020. , ...
(Date:5/15/2020)... ... May 15, 2020 , ... The National Institutes of Health (NIH) has ... in Frederick, Maryland and Tysons Corner, Virginia, to provide patent legal services under two ... in the field of chemistry. The firm is one of nine firms in the ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... ... May 05, 2020 , ... ... today the launch of its iGlucose® LTE Cat-M Cellular Connected Diabetes ... LTE Cat-M1 technology, the industry’s newest and broadest cellular connectivity available, to provide ...
(Date:4/22/2020)... , ... April 20, 2020 , ... ... in Cambridge, MA, announced today that Omixon’s founder and chairman Dr. Attila Berces ... Omixon’s flagship product Holotype HLA since 2014 before stepping into the CEO role ...
(Date:4/7/2020)... ... 06, 2020 , ... Gateway Genomics , leading developer of direct-to-consumer genetic ... Gender DNA Tests sold in March, just months after attaining the 150,000-test landmark ... where a mom could order her kit online, collect a DNA sample from her ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... has developed a method using its revolutionary NEXTGENPCR endpoint thermocycler and consumables ... smaller reaction volumes, increased samples per run, and standard, affordable laboratory equipment, ...
Breaking Biology Technology:
Cached News: